Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
5,822,045
-
Share change
-
-187,046
-
Total reported value
-
$32,606,017
-
Put/Call ratio
-
41%
-
Price per share
-
$5.60
-
Number of holders
-
33
-
Value change
-
-$1,045,996
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2017
As of 31 Dec 2017 Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) had 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,822,045 shares of stock of the company.
Largest 10 holders included JPMORGAN CHASE & CO, FMR LLC, ROYCE & ASSOCIATES LP, Vanguard Group Inc, STIFEL FINANCIAL CORP, SPHERA FUNDS MANAGEMENT LTD., Opus Point Partners Management, LLC, MILLENNIUM MANAGEMENT LLC, Allianz Asset Management GmbH, and Alethea Capital Management, LLC.
This table shows 33 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.